Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saakshi Medtech and PanelsNSE:SAAKSHI -1.43%50 Altman Z-Score is 9.20 as of Sep. 12, 2026, which is 59% above its 10-year median of 5.77. GuruFocus rates NSE:SAAKSHI with a GF Score™ of 50/100 and a GF Value™ of ₹220.57 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 3,021 Industrial Products companies, Saakshi Medtech and Panels ranks better than 85.9% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 8.56 is strong.
Saakshi Medtech and Panels has a Altman Z-Score of 9.20, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Saakshi Medtech and Panels's Altman Z-Score or its related term are showing as below:
NSE:SAAKSHI'
s Altman Z-Score Range Over the Past 10 Years
Min: 5.35 Med: 5.77 Max: 8.56
Current: 8.56
During the past 7 years, Saakshi Medtech and Panels's highest Altman Z-Score was 8.56. The lowest was 5.35. And the median was 5.77.
Saakshi Medtech and Panels (NSE:SAAKSHI) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electrical Equipment & Parts subindustry, Saakshi Medtech and Panels's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saakshi Medtech and Panels Altman Z-Score vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Saakshi Medtech and Panels's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Saakshi Medtech and Panels's Altman Z-Score falls into.
Saakshi Medtech and Panels Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Saakshi Medtech and Panels (NSE:SAAKSHI) has a Altman Z-Score of 9.20 as of Sep. 12, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Saakshi Medtech and Panels and its competitors. This is 59% above median its historical median of 5.77. Over the past decade, Saakshi Medtech and Panels' Altman Z-Score has ranged from 5.35 to 8.56. According to the industry distribution chart, Saakshi Medtech and Panels ranks #426 out of 3021 companies in the Industrial Products industry, placing it in the top 14.1%.
Is Saakshi Medtech and Panels' Altman Z-Score too high?
Saakshi Medtech and Panels' current Altman Z-Score of 9.20 is 59% above median its 10-year median of 5.77. Over the past 10 years, this metric has ranged from a low of 5.35 to a high of 8.56. The Industrial Products industry median Altman Z-Score is 3.26. Saakshi Medtech and Panels' value of 9.20 is 182.2% above this industry median. Based on the distribution chart, Saakshi Medtech and Panels ranks #426 out of 3021 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Saakshi Medtech and Panels has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Saakshi Medtech and Panels' Altman Z-Score compare to VRT and BE?
According to the Industrial Products industry distribution chart, Saakshi Medtech and Panels ranks #426 out of 3021 companies for Altman Z-Score. This places Saakshi Medtech and Panels in the top 14% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 3.26. Saakshi Medtech and Panels' value of 9.20 is 182.2% above this benchmark. Historically, Saakshi Medtech and Panels' own Altman Z-Score has ranged from 5.35 to 8.56 over the past decade. While the company's 10-year median is 5.77 vs. the industry median of 3.26, Saakshi Medtech and Panels has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for an Industrial Products company?
The median Altman Z-Score among Industrial Products companies is 3.26, based on 3,021 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saakshi Medtech and Panels's current Altman Z-Score of 9.20 is 182.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Saakshi Medtech and Panels and its competitors. For the Industrial Products industry, the median Altman Z-Score is 3.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saakshi Medtech and Panels's current Altman Z-Score is 9.20, which is 59% above median its own 10-year median of 5.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saakshi Medtech and Panels stock overvalued right now?
Based on GuruFocus' analysis, Saakshi Medtech and Panels (NSE:SAAKSHI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹220.57, compared to a current price of ₹345.40 — trading 56.6% above its estimated fair value. The current Altman Z-Score is 9.20, which is 59% above median its 10-year median of 5.77 and 182.2% above the Industrial Products industry median of 3.26. Saakshi Medtech and Panels' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Saakshi Medtech and Panels (NSE:SAAKSHI), the current Altman Z-Score is 9.20 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saakshi Medtech and Panels (NSE:SAAKSHI) Overvalued in 2026?
Based on GuruFocus' analysis, Saakshi Medtech and Panels stock appears to be overvalued.
The current stock price of ₹345.40 is trading 56.6% above its estimated GF Value™ of ₹220.57.
GuruFocus considers Saakshi Medtech and Panels to be Significantly Overvalued.
Key valuation signals for NSE:SAAKSHI:
Altman Z-Score: 9.20 (59% above median its 10-year median of 5.77)
GF Value™: ₹220.57 vs. price of ₹345.40 (56.6% above fair value)
Industry Position: 182.2% above the Industrial Products median (#426 of 3021)
No single metric tells the full story. See the NSE:SAAKSHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saakshi Medtech and Panels Ltd is a diversified company engaged in manufacturing Electrical Control Panels and Cabinets used in elevators, air compressors, renewable energy industry, oil & gas exploration industry, electrical vehicle charging stations, medical X-Ray Systems used in healthcare industry, fabrication works for locomotives, and wire harness division for their captive consumption in electrical control panels and for supply to air compressor industry. Their comprehensive solutions include design, process engineering, and manufacturing including fabrication, assembly, and testing facilities. It designs, programs, and assembles Electrical Control Panels and Cabinets comprising microcontrollers, programmable logic controllers, and SCADA systems.
50GF Score
Get the complete analysis for NSE:SAAKSHI
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAAKSHI has been successfully added to your 
